Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Paper of the day - aspirin fails to cut VTE risk

Long-term low-dose aspirin use does not seem to reduce the risk of venous thromboembolism, latest results from the Women's Health Study suggest.

A total of 39,876 healthy US women aged over 45 were randomised to receive aspirin or vitamin E every other day over an average of 10 years' follow-up.

VTE events occurred in 482. Although women taking aspirin were slightly less likely to have a VTE event, the difference was small and not statistically significant, for either provoked or unprovoked events. Researchers concluded that aspirin had no beneficial effects on participants' risk of VTE including a subgroup of women with genetic mutations associated with VTE.

Annals of Internal Medicine 2007;147:525-33

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say